Septodont Invests in Balanced Pharma, Joins Board
Dental News and Technology
JANUARY 24, 2025
market in Q4 2027 and follow on with BPI-002 and expansion into global markets. Notably, both drugs will continue to be provided in a standard dental cartridge, providing a seamless replacement for current products without the need for any additional devices or change in clinical protocol. Balanced Pharma intends to bring BPI-001, to the U.S.
Let's personalize your content